Pharmaceutical

Image

Global Middle East Respiratory Syndrome (MERS) Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Middle East Respiratory Syndrome (MERS) Market, By Product (REGN3048, REGN3051, GLS-5300, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Middle East Respiratory Syndrome (MERS) Market

Global Middle East Respiratory Syndrome (MERS) Market Analysis and Size

The Middle East respiratory syndrome (MERS) market is expected to witness significant growth during the forecast period. increased prevalence of MERS, continuous clinical studies going on the to overcome MERS viral infection and strong surveillance & control by the WHO, UNICEF and other government authorities to treat infection will boost up the global middle east respiratory syndrome (MERS) market. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the Middle East respiratory syndrome (MERS) market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Middle East respiratory syndrome (MERS) is a viral respiratory infection caused by the novel coronavirus, also referred as MERS-CoV and first identified in Saudi Arabia in 2012. Coronaviruses are the large family of virus causes common cold, fever to Severe Acute Respiratory Syndrome (SARS). Symptoms of MERS include cough, fever, breathing problem, pneumonia but not always present. Gastrointestinal symptoms, including diarrhea, have also been reported. Some patient of MERS-CoV infection reported asymptomatic (that is they do not have any symptoms of infection) but they are positive for MERS-CoV infection and infect other.   

Global Middle East Respiratory Syndrome (MERS) Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product (REGN3048, REGN3051, GLS-5300, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

GeneOne Life Science (South Korea), INOVIO Pharmaceuticals (U.S.), Pfizer Inc.(U.S.), Regeneron Pharmaceuticals Inc (U.S.), Astellas Pharma Inc. (Japan), Merck KGaA (Germany), Sanofi (France), Biocare Medical, LLC (U.S.), Lilly (U.S.), Teva Pharmaceutical Industries Ltd (Israel)

Market Opportunities

  • Increased Clinical Studies and Government Initiatives
  • Increasing Demand for Retail Pharmacies

Global Middle East Respiratory Syndrome (MERS) Market Dynamics

Drivers

  • Recent Advances in the Vaccine Development for MERS

The disease is dangerous and becoming more prevalent but still there is no specific treatment proven effective against this viral disease. Several vaccine candidates are developed that gives hope in saving the patients from this dreadful disease. Candidates such as viral vector-based vaccine, subunit vaccine, DNA vaccine, nanoparticle-based vaccine, live-attenuated vaccine and inactivated-whole virus vaccine are expected to improve the immune response of the patients

  • Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

  • Increased Clinical Studies and Government Initiatives

Rising awareness about the drugs and studies that are conducted for development in identifying the harmful compositions for the body that by government and private companies for better knowledge of these drugs and antidotes is likely to drive the market growth.

  • Increasing Demand for Retail Pharmacies

Rise in the number of narcotic drugs being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with these agents could curb the growth of the global Middle East respiratory syndrome (MERS) market over a forecast period.

  • High Cost

The huge expenditure associated with these agents surely hamper the market growth.

This global Middle East respiratory syndrome (MERS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global Middle East respiratory syndrome (MERS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Middle East Respiratory Syndrome (MERS) Market         

Although with the rise in COVID-19, the focus on MERS has been diverted. Hospitals and clinics are getting occupied with COVID-19 patients. The health threats and economic burden caused by these coronaviruses are extremely terrible and getting more serious as the rising number of global infections and attributed deaths of SARS-CoV-2 and MERS-CoV. Thus, COVID-19 left a good impact on the lives of the population.

Global Middle East Respiratory Syndrome (MERS) Market Scope

The Middle East respiratory syndrome (MERS) market is segmented on the product, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • REGN3048
  • REGN3051
  • GLS-5300
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Middle East Respiratory Syndrome (MERS) Market Regional Analysis/Insights

The global Middle East respiratory syndrome (MERS) market is analysed and market size insights and trends are provided by product, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global Middle East respiratory syndrome (MERS) market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global Middle East respiratory syndrome (MERS) market throughout the forecasted period due to the global leaders in research and development activities, established framework of approval process and increase in number of FDA approval drugs.

North America dominates the market due to presence of advanced technology, affordable reimbursement scenario encourages growth and high R&D & healthcare expenditure.

Middle-East and Asia-Pacific has the largest lucrative growth due to presence of generic manufacturers and increased prevalence of respiratory infections.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Middle East Respiratory Syndrome (MERS) Market Share Analysis

The global Middle East respiratory syndrome (MERS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global Middle East respiratory syndrome (MERS) market

Key players operating in the global Middle East respiratory syndrome (MERS) market include:

  • GeneOne Life Science (South Korea)
  • INOVIO Pharmaceuticals (U.S.)
  • Pfizer Inc.(U.S.)
  • Regeneron Pharmaceuticals Inc (U.S.)
  • Astellas Pharma Inc. (Japan)
  • Merck KGaA (Germany)
  • Sanofi (France)
  • Biocare Medical, LLC (U.S.)
  • Lilly (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Factors such as recent advances in the vaccine development for MERS and rising demand for oral drugs are acting as the major drivers for the global Middle East respiratory syndrome (MERS) market.
The major players are GeneOne Life Science (South Korea), INOVIO Pharmaceuticals (U.S.), Pfizer Inc.(U.S.), Regeneron Pharmaceuticals Inc (U.S.), Astellas Pharma Inc. (Japan), Merck KGaA (Germany), Sanofi (France), Biocare Medical, LLC (U.S.), Lilly (U.S.), Teva Pharmaceutical Industries Ltd (Israel)
The major countries covered in the Middle East Respiratory Syndrome (MERS) Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The segments analyzed in the report are product, route of administration, distribution channel and end-user.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials